Carregant...
Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA
BACKGROUND: Despite having unquestionable glucose lowering efficacy, current guidelines no more favour the uses of sulphonylureas for CV safety concern, except when cost is an issue. However, formal cardiovascular outcome trial (CVOT) is not available. MATERIALS AND METHODS: We performed an indirect...
Guardat en:
| Publicat a: | Diab Vasc Dis Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7919221/ https://ncbi.nlm.nih.gov/pubmed/33213193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120973653 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|